ReviewAdvances in therapy2019

Hematopoietic Stem Cell Transplantation and Brentuximab Vedotin for Patients with Relapsed or Refractory Hodgkin Lymphoma and Systemic Anaplastic Large-Cell Lymphoma.

Kenichi Ishizawa et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.